Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Kantor

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Virulence|May 9, 2014
Virulence profile: Rami KantorRami Kantor
Current Opinion in Infectious Diseases|November 1, 2006
Impact of HIV-1 pol diversity on drug resistance and its clinical implicationsRami Kantor
Rhode Island Medical Journal (2013)|October 3, 2013
Research components of the Brown Kenya Program: a personal and professional perspectiveRami Kantor
Viruses|March 6, 2021
Next Generation Sequencing for HIV-1 Drug Resistance Testing-A Special Issue WalkthroughRami Kantor
The Lancet. HIV|October 13, 2023
INSTI era resistance: emerging concern or marginal issue?Rami Kantor
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 14, 2004
Drug resistance in non-subtype B HIV-1Rami Kantor, David Katzenstein
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
Approaches for guideline versioning using GLIFMor Peleg, Rami Kantor
AIDS Reviews|July 24, 2003
Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolutionRami Kantor, David Katzenstein
The Lancet. HIV|January 7, 2023
We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapyRami Kantor, Ravindra K Gupta
HIV Therapy|February 18, 2010
Transmitted drug resistance in nonsubtype B HIV-1 infectionPhilip A Chan, Rami Kantor
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Virulence|May 9, 2014
Virulence profile: Rami KantorRami Kantor
Current Opinion in Infectious Diseases|November 1, 2006
Impact of HIV-1 pol diversity on drug resistance and its clinical implicationsRami Kantor
Rhode Island Medical Journal (2013)|October 3, 2013
Research components of the Brown Kenya Program: a personal and professional perspectiveRami Kantor
Viruses|March 6, 2021
Next Generation Sequencing for HIV-1 Drug Resistance Testing-A Special Issue WalkthroughRami Kantor
The Lancet. HIV|October 13, 2023
INSTI era resistance: emerging concern or marginal issue?Rami Kantor
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 14, 2004
Drug resistance in non-subtype B HIV-1Rami Kantor, David Katzenstein
AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 20, 2004
Approaches for guideline versioning using GLIFMor Peleg, Rami Kantor
AIDS Reviews|July 24, 2003
Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolutionRami Kantor, David Katzenstein
The Lancet. HIV|January 7, 2023
We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapyRami Kantor, Ravindra K Gupta
HIV Therapy|February 18, 2010
Transmitted drug resistance in nonsubtype B HIV-1 infectionPhilip A Chan, Rami Kantor
Pageof 17